CLST Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
3.9M
+0.6%
3.9M
+6.2%
3.7M
-3.5%
3.8M
+0.6%
3.8M
Cost of Revenue
993.0K
-3.1%
1.0M
-1.5%
1.0M
-2.1%
1.1M
+7.0%
993.0K
Gross Profit
3.0M
+1.9%
2.9M
+9.2%
2.7M
-4.1%
2.8M
-1.7%
2.8M
Operating Expenses
2.4M
+4.2%
2.3M
+13.8%
2.0M
-8.9%
2.2M
+1.1%
2.2M
R&D
SG&A
737.0K
+1.2%
728.0K
+14.6%
635.0K
-2.0%
648.0K
+2.0%
635.0K
Operating Income
676.0K
-1.2%
684.0K
+24.1%
551.0K
-8.0%
599.0K
-5.5%
634.0K
EBITDA
676.0K
-1.2%
684.0K
+24.1%
551.0K
-8.0%
599.0K
-5.5%
634.0K
Net Income
524.0K
-6.1%
558.0K
+22.4%
456.0K
-6.7%
489.0K
-6.1%
521.0K
EPS (Basic)
$0.15
-6.3%
$0.16
+23.1%
$0.13
+0.0%
$0.13
-7.1%
$0.14
EPS (Diluted)
$0.14
-6.7%
$0.15
+15.4%
$0.13
+0.0%
$0.13
-7.1%
$0.14
Shares (Diluted)
3.6M
+0.2%
3.6M
-0.1%
3.6M
-0.4%
3.7M
-0.4%
3.7M
Catalyst Ban (CLST) — Financials